Yuan Wang
Hanzhong, 723001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
TGFA promotes the development of cervical cancer via interacting with DSG2.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 19, 2026
Expression of BmSPI38 tandem multimers in Escherichia coli and its antifungal activity
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: October 25, 2023
Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
Journal: PloS one
Published: May 10, 2023
Amino Acid Substitutions at P1 Position Change the Inhibitory Activity and Specificity of Protease Inhibitors BmSPI38 and BmSPI39 from Bombyx mori.
Journal: Molecules (Basel, Switzerland)
Published: January 31, 2023
Tandem Multimerization Can Enhance the Structural Homogeneity and Antifungal Activity of the Silkworm Protease Inhibitor BmSPI39.
Journal: Cells
Published: December 23, 2022
Analysis of the Effect of Fast Recovery Surgery Concept on Perioperative Nursing Care of Patients with Radical Resection of Cervical Cancer and Its Influence on Psychological Status.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: May 16, 2022
Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer.
Journal: The Kaohsiung journal of medical sciences
Published: November 02, 2020
MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6.
Journal: Journal of biosciences
Published: January 03, 2020
Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: October 25, 2019
Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
Journal: Cell cycle (Georgetown, Tex.)
Published: June 12, 2018
The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
Journal: Investigational new drugs
Published: April 13, 2018
Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Journal: Cancer biology & therapy
Published: February 06, 2018
Last Updated: 09/26/2026